Cobitolimod
Cobitolimod is a TLR9 agonist oligonucleotide that modulates immune responses by suppressing Th17 activity and promoting anti-inflammatory FoxP3 and IL-10 expression, thereby inhibiting IL-17 signaling. It is used in research for inflammatory bowel disease models, demonstrating efficacy in both in vitro immune cell assays and in vivo preclinical studies.
Product Specifications
CAS Number
1226822-98-5
Field of Research
Immunology & Inflammation
Molecular Formula
C185H233N73O106P18S6
Molecular Weight
5925.2
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
